Patents Assigned to Roche Diagnostics Operation, Inc.
  • Patent number: 7271252
    Abstract: The invention provides derivatives of efavirenz and methods of making derivatives of efavirenz. The derivatives include immunogenic compounds for producing antibodies to efavirenz and labeled efavirenz tracers. These compounds are useful in immunoassay methods for determining efavirenz.
    Type: Grant
    Filed: April 22, 2003
    Date of Patent: September 18, 2007
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Gerald F. Sigler, Mitali Ghoshal, Lili Arabshahi
  • Patent number: 7264938
    Abstract: The present invention relates to antibodies specifically binding to native proBNP, a method for specific detection of native proBNP, a method of correlating the level of native proBNP to the diagnosis of heart failure, a kit for detection of native proBNP and to a hybridoma cell line producing an antibody to native proBNP.
    Type: Grant
    Filed: November 10, 2005
    Date of Patent: September 4, 2007
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Anneliese Borgya, Andreas Gallusser, Michael Grol, Klaus Hallermayer, Volker Klemt, Christoph Seidel
  • Patent number: 7264627
    Abstract: A sampling member defines a passageway including an inlet opening for reception of a bodily fluid therein, and a wicking member having a first portion coupled with the sampling member adjacent to the inlet opening. The wicking member further includes a second portion displaced from the first portion for initially contacting the bodily fluid. In use the sampling member is placed adjacent to an incision site with the second portion of the wicking member positioned to have the bodily fluid first contact the wicking member and thereby draw the fluid from the incision site to the inlet opening. In related embodiments there is provided a sampling system and method which further includes a lancing device to create the incision and optionally expression members to urge the bodily fluid from the incision, preferably in an integrated unit.
    Type: Grant
    Filed: August 29, 2002
    Date of Patent: September 4, 2007
    Assignee: Roche Diagnostics Operations, Inc.
    Inventor: Edward Perez
  • Patent number: 7264939
    Abstract: The present invention relates to antibodies specifically binding to native proBNP, a method for specific detection of native proBNP, a method of correlating the level of native proBNP to the diagnosis of heart failure, a kit for detection of native proBNP and to a hybridoma cell line producing an antibody to native proBNP.
    Type: Grant
    Filed: November 10, 2005
    Date of Patent: September 4, 2007
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Anneliese Borgya, Andreas Gallusser, Michael Grol, Klaus Hallermayer, Volker Klemt, Christoph Seidel
  • Publication number: 20070202007
    Abstract: The invention concerns a test element analytical system for the analytical examination of a sample, especially a body fluid, comprising at least one test element with one or more measuring zones and contact areas located on the test element, in particular electrodes or conductor paths, the sample to be examined being brought into the measuring zone to carry out an analysis in order to determine a characteristic measured quantity for the analysis, and an evaluation instrument with a test element holder for positioning the test element in a measuring position and a measuring device for measuring the characteristic change, the test element holder containing contact elements with contact areas which enable an electrical contact between the contact areas of the test element and the contact areas of the test element holder, characterized in that one of these contact areas is provided with an electrically conductive hard material surface.
    Type: Application
    Filed: August 21, 2006
    Publication date: August 30, 2007
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Manfred Augstein, Joerg Dreibholz, Stefan Riebel
  • Patent number: 7262306
    Abstract: The present invention relates to novel chemiluminescent compounds, to a method for synthesizing these compounds, to derivatives and conjugates comprising these compounds, to the use of these compounds or conjugates thereof in chemiluminescence based assays, especially in immunoassays.
    Type: Grant
    Filed: January 6, 2006
    Date of Patent: August 28, 2007
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Wolfgang Jenni, Dieter Heindl, Rupert Herrmann, Hans-Peter Josel, Gunter Lampert
  • Patent number: 7256054
    Abstract: Colloidal metal particles having a coating comprising non cross-linked, SH-activated dextran or aminodextran. Biomolecules may be linked directly or indirectly to the particles, which are useful as detection reagents in immunological assays.
    Type: Grant
    Filed: June 6, 2001
    Date of Patent: August 14, 2007
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Peter Sluka, Sebastian Heimerl, Konrad Kuerzinger, Thomas Fischer
  • Publication number: 20070184672
    Abstract: A micro fluidic device comprises a laminate structure, comprising a plurality of individual layers. At least one layer comprises a micro fluidic channel structure and at least on one side of said layer a further layer is arranged comprising a three-dimensional (3D) micro structure such that the 3D micro structure is influencing a flow characteristic of a fluid within the micro fluidic channel structure.
    Type: Application
    Filed: January 31, 2007
    Publication date: August 9, 2007
    Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.
    Inventors: Roger Sandoz, Carlo Effenhauser
  • Publication number: 20070184506
    Abstract: The invention concerns a test element for carrying out an immunological sandwich test for determining an analyte from a liquid sample containing a reagent zone or conjugate zone which contains a conjugate of an analyte binding partner and a label which can be detected directly or indirectly by visual, optical or electrochemical means (e.g., an enzyme, fluorescent or direct label, etc.) wherein the conjugate can be dissolved by the liquid sample, a detection zone which contains a permanently immobilized (i.e., which cannot be detached by the liquid sample) binding partner for the analyte or for complexes containing the analyte; and a control zone which contains a permanently immobilized binding partner for the conjugate of analyte binding partner and label characterized in that the control zone additionally contains one or more permanently immobilized binding partner(s) for the analyte or for complexes containing the analyte.
    Type: Application
    Filed: January 12, 2007
    Publication date: August 9, 2007
    Applicant: Roche Diagnostics Operations, Inc.
    Inventor: Juergen Klepp
  • Publication number: 20070170054
    Abstract: Analytes in a liquid sample are determined by methods utilizing sample volumes of less than about 1.5 ?l and test times within ten seconds. The methods are preferably performed using small test strips including a sample receiving chamber filled with the sample by capillary action.
    Type: Application
    Filed: March 5, 2003
    Publication date: July 26, 2007
    Applicants: Roche Diagnostics Operations, Inc., Corange International Limited
    Inventor: Christopher Wilsey
  • Publication number: 20070170055
    Abstract: Described are micro-arrays of electrodes disposed proximal to a flexible substrate, electronic components and sensors comprising such arrays, and methods of use for such arrays.
    Type: Application
    Filed: October 4, 2002
    Publication date: July 26, 2007
    Applicants: Roche Diagnostics Operations, Inc., Corange International Limited
    Inventor: Christopher Wilsey
  • Patent number: 7247144
    Abstract: A sampling device for sampling body fluid includes a lancet for making an incision, a capillary tube for drawing-up body fluid from the incision, and a test strip affixed to an upper end of the capillary tube for receiving the fluid. An absorbent pad can be disposed between the test strip and capillary tube for spreading-out the fluid being transferred to the test strip. An on-site analyzer such as an optical analyzer and/or an electrochemical analyzer can be mounted in the device for analyzing the fluid. Alternatively, a test strip can be slid through a slot formed in the bottom end of the device so that by passing the device against the skin after an incision has been formed, the test strip will directly contact body fluid emanating from the incision.
    Type: Grant
    Filed: July 3, 2003
    Date of Patent: July 24, 2007
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Joel S. Douglas, Jeffrey N. Roe, Ryszard Radwanski, Brent G. Duchon
  • Publication number: 20070166193
    Abstract: A reagent kit adapted for being used in an automatic analytical apparatus. The reagent kit comprises at least a first reagent container and a second reagent container which have the same height, a kit cover for covering and for holding the upper parts of said at least two reagent containers together, a first tray for holding the bottom part of the first reagent container, and a second tray for holding the bottom part of the second reagent container. Reagent containers are so configured and dimensioned that when they are assembled together they fill the entire space comprised between kit cover and the trays with exception of a tubular volume which allows air circulation through said reagent kit. The sum of the height of the side walls of the kit cover and the height of the side walls of the trays is smaller than the height of the reagent containers.
    Type: Application
    Filed: January 11, 2007
    Publication date: July 19, 2007
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Gerhard Veen, Peter Fanger
  • Patent number: 7244264
    Abstract: An integrated lancing test strip includes a pair of blade members that each have a lancing tip that are configured to lance skin. A pair of spacer members connect the blade members together such that the blade members define an internal capillary. A test strip is positioned along the internal capillary, and the test strip is configured to test analyte levels in the bodily fluid. During use, the lancing tips form one or more incisions in the skin. The fluid from the incisions is drawn via capillary action through the internal capillary and onto the test strip.
    Type: Grant
    Filed: December 3, 2002
    Date of Patent: July 17, 2007
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Steven N. Roe, Jeffrey N. Roe
  • Patent number: 7244266
    Abstract: Lancet system for pain-reduced blood withdrawal comprising an impulse generator which exerts an impulse on a body part in a sequence which is synchronized with the movement of a lancet. Method for the pain-reduced blood withdrawal in which an impulse is exerted on an adjacent body part in a sequence which is synchronized with the generation of an opening in the skin.
    Type: Grant
    Filed: February 7, 2003
    Date of Patent: July 17, 2007
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Claus-Dieter Garthe, Peter Ruschke, Guenther Schmelzeisen-Redeker, Claudio Immekus, Uschi Wolf, Klemens Masuch, Hans List
  • Patent number: 7244819
    Abstract: The present invention relates to the cloning and expression of foreign protein or polypeptides in bacteria, such as Escherichia coli. In particular, this invention relates to expression tools comprising a FKBP-type peptidyl prolyl isomerase selected from the group consisting of FkpA, SlyD, and trigger factor; methods of recombinant protein expression, the recombinant polypeptides thus obtained, as well as to the use of such polypeptides.
    Type: Grant
    Filed: June 24, 2002
    Date of Patent: July 17, 2007
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Christian Scholz, Herbert Andres, Elke Faatz, Alfred Engel, Urban Schmitt, Ariuna Bazarsuren, Peter Schaarschmidt
  • Publication number: 20070151854
    Abstract: A device providing an arrangement for the separation of a sample mixture for analytical reasons based on multidimensional gel electrophoresis and method thereof are disclosed. The separation involves a first separation in a first dimension of the device on the basis of isoelectric points and a second separation in a second dimension of the device on the basis of molecular size. At least two gel strips for the first dimension separation step and a corresponding gel for the second dimension separation step are provided. The two gel strips are arranged on a single carrier either on the same side or on opposite sides. By having at least two gel strips arranged in such a manner at least two analytical processes can be executed in parallel on the single carrier without the use of valves.
    Type: Application
    Filed: December 20, 2006
    Publication date: July 5, 2007
    Applicant: Roche Diagnostics Operations, Inc.
    Inventor: Mario Curcio
  • Patent number: 7238192
    Abstract: A blood withdrawal system for withdrawing blood for diagnostic purposes including a lancing device having a housing with an opening and a support surface, and a lancet holder movably mounted in the opening including a lancet and a bearing member that rests on the support surface. The device further includes a trigger unit which, when moved linearly, causes a rotational movement to initiate a lancing process.
    Type: Grant
    Filed: May 14, 2003
    Date of Patent: July 3, 2007
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Hans List, Peter Ruschke, Brian VanHiel, Bradley Koeppel, Gwenn Kennedy
  • Patent number: 7238791
    Abstract: Analogs of 6-monoacetyl morphine (6-MAM) are described. These include analogs derivatized at either the C-3 position, the C-6 position, or the nor position of the molecule. These analogs allow for elaboration with linkers terminated by a functional group such as an activated ester, the functional groups being useful for attaching the molecule to other entities such as proteins, polysaccharides, and reporter groups.
    Type: Grant
    Filed: December 16, 2005
    Date of Patent: July 3, 2007
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Mitali Ghoshal, Gerald F. Sigler
  • Patent number: D550363
    Type: Grant
    Filed: July 28, 2005
    Date of Patent: September 4, 2007
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Matthew Hannant, James West